G1T28
- CAS No.
- 1977495-97-8
- Chemical Name:
- G1T28
- Synonyms
- G1T28;Trilaciclib HCl;Trilaciclib DiHCl;G1T28 hydrochloride;Trasylide hydrochloride;Trilaciclib hydrochloride;Trilaciclib dihydrochloride;Trilaciclib hydrochloride(G1T28);Trilaciclib Impurity(Dihydrochloride);Inhibitor,Trilaciclib hydrochloride,CDK,Cyclin dependent kinase,inhibit,Trilaciclib,G1T28
- CBNumber:
- CB03335415
- Molecular Formula:
- C24H31ClN8O
- Molecular Weight:
- 483.02
- MDL Number:
- MFCD31630829
- MOL File:
- 1977495-97-8.mol
storage temp. | Store at -20°C |
---|---|
form | Solid |
color | Light yellow to yellow |
Water Solubility | Water : ≥ 100 mg/mL (192.50 mM) |
FDA UNII | 4BX07W725T |
G1T28 price
Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|---|
ChemScene | CS-7942 | Trilaciclib(hydrochloride) 99.24% | 1977495-97-8 | 5mg | $700 | 2021-12-16 | Buy |
ChemScene | CS-7942 | Trilaciclib(hydrochloride) 99.24% | 1977495-97-8 | 10mg | $950 | 2021-12-16 | Buy |
ChemScene | CS-7942 | Trilaciclib(hydrochloride) 99.24% | 1977495-97-8 | 100mg | $2400 | 2021-12-16 | Buy |
DC Chemicals | DC21033 | Trilaciclibhydrochloride(G1T28) >98% | 1977495-97-8 | 250mg | $1500 | 2021-12-16 | Buy |
DC Chemicals | DC21033 | Trilaciclibhydrochloride(G1T28) >98% | 1977495-97-8 | 100mg | $800 | 2021-12-16 | Buy |
G1T28 Chemical Properties,Uses,Production
Uses
Trilaciclib (G1T28) hydrochloride is an orally active CDK4/6 inhibitor with IC50 values of 1 nM and 4 nM for CDK4 and CDK6, respectively. Trilaciclib hydrochloride can effectively inhibit tumor cell proliferation and reduce the hematological toxicity caused by chemotherapy. Trilaciclib hydrochloride attenuates apoptosis and myelosuppression induced by 5FU (HY-90006) chemotherapy[1].
in vivo
Trilaciclib hydrochloride (50-150 mg/kg; po; single dose) protects mouse bone marrow cells from chemotherapy-induced apoptosis and attenuates chemotherapy-induced myelosuppression in vivo. Trilaciclib hydrochloride at 150 mg/kg reduces HSPC damage induced by 5FU (150 mg/kg; ip) chemotherapy, thereby accelerating blood count recovery after chemotherapy[1].
Animal Model: | FVB/n female C57Bl6 mice[1] |
Dosage: | 50, 100, 150 mg/kg |
Administration: | Po; single dose; treated followed 11 or 23 hours later by a single injection of EdU (HY-118411) (100 μg; ip); mouse were euthanized 1 hour after EdU injection. |
Result: | Showed a dose-dependent decrease in caspase 3/7 activation. Attenuated chemotherapy-induced myelosuppression in mice. |
IC 50
Cdk4/cyclin D1: 1 nM (IC50); cdk6/cyclin D3: 4 nM (IC50)
References
[1] Bisi JE, et al. Preclinical Characterization of G1T28: A Novel CDK4/6 Inhibitor for Reduction of Chemotherapy-Induced Myelosuppression. Mol Cancer Ther. 2016 May;15(5):783-93. DOI:10.1158/1535-7163.MCT-15-0775
G1T28 Preparation Products And Raw materials
Raw materials
Preparation Products
G1T28 Suppliers
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
Jinan Carbotang Biotech Co.,Ltd. | +8615866703830 | figo.gao@foxmail.com | China | 8497 | 58 |
TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 | marketing@targetmol.com | United States | 32159 | 58 |
Wuhan Demeikai Biotechnology Co., Ltd | +8618942921723 | info@dmksw.xin | China | 717 | 58 |
InvivoChem | +1-708-310-1919 +1-13798911105 | sales@invivochem.cn | United States | 6391 | 58 |
BTC pharm India | +918790379245 | banny.janga@btcpharm.com | India | 1262 | 58 |
Hangzhou MolCore BioPharmatech Co.,Ltd. | +86-057181025280; +8617767106207 | sales@molcore.com | China | 49734 | 58 |
TargetMol Chemicals Inc. | support@targetmol.com | United States | 38630 | 58 | |
Shanghai Guangyang Jiali Biotechnology Co., Ltd | 13407521611 | 46993711@qq.com | China | 176 | 58 |
Suzhou ARTK Medchem Co., Ltd. | +86-512-68323658 +86-18168183658 | sales1@artkmedchem.com | China | 39003 | 58 |
Wuhan Jingkang en Biomedical Technology Co., Ltd | +8613720134139 | orders@jknbiochem.com | China | 5221 | 58 |
View Lastest Price from G1T28 manufacturers
Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
---|---|---|---|---|---|---|---|---|
![]() |
2024-11-19 | Trilaciclib hydrochloride
1977495-97-8
|
US $31.00-163.00 / mg | 99.69% | 10g | TargetMol Chemicals Inc. | ||
![]() |
2024-11-19 | Trilaciclib hydrochloride
1977495-97-8
|
US $31.00-163.00 / mg | 99.69% | 10g | TargetMol Chemicals Inc. |
-
- Trilaciclib hydrochloride
1977495-97-8
- US $31.00-163.00 / mg
- 99.69%
- TargetMol Chemicals Inc.
-
- Trilaciclib hydrochloride
1977495-97-8
- US $31.00-163.00 / mg
- 99.69%
- TargetMol Chemicals Inc.